Physician profile
Amanda Sing
NPI 1508485749
$700.30
in general payments reported to CMS, 2019-2025
17 companies · $566 in 2025
The $566 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $134 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $92.98 | 2025 | Airsupra |
| Novo Nordisk INC | $85.62 | 2025 | Wegovy, Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.70 | 2022-2025 | Xifaxan |
| Abbvie INC. | $80.83 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $78.47 | 2022-2025 | Lagevrio, Gardasil 9, Capvaxive |
| Lilly USA, LLC | $61.66 | 2025 | Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $39.78 | 2022 | |
| Shield Therapeutics INC | $31.01 | 2025 | |
| Intuitive Surgical, INC. | $19.57 | 2025 | |
| Pfizer INC. | $19.37 | 2025 | |
| Dexcom, INC. | $16.19 | 2025 | Dexcom G6 Transmitter |
| Paratek Pharmaceuticals, INC. | $16.18 | 2025 | Nuzyra, Xhance |
| Eisai INC. | $16.05 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.86 | 2022 | |
| Amgen INC. | $15.21 | 2025 | Otezla, Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $15.14 | 2025 | NP Thyroid 60 |
| Exact Sciences Corporation | $13.68 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Sing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.